Jeremy Curnock Cook
Non-Executive Director
Infectious Diseases
Avita Medical
Australia
Biography
Mr Curnock Cook was appointed to the Board on 19 October 2012 and is currently on a number of boards of International Healthcare and Biotechnology companies. He is the former head of the life science private equity team at Rothschild Asset Management, was responsible for the launch of the first dedicated biotechnology fund for the Australian market and the conception and launch of the International Biotechnology Trust. He is currently the Managing Director of Bioscience Managers Pty Ltd, responsible for the BM Asia Pacific Heathcare Fund. During the past three years Mr Curnock Cook has also served as a director of the following other listed companies: Bioxyne Ltd (Appointed 7 May 2012 – resigned July 2014) Phylogica Ltd* (Appointed March 2012) AmpliPhi Bioscience Corporation Inc* (Appointed July 1995) Sea Dragon Marine Oils Ltd* (Appointed 15 October 2012) Eacom Timber Corporation (Appointed 1997 – resigned June 2013) Rex Bionics plc* (Appointed 27 February 2012) Adherium Ltd* (Appointed July 2015)
Research Interest
Mr Curnock Cook was appointed to the Board on 19 October 2012 and is currently on a number of boards of International Healthcare and Biotechnology companies. He is the former head of the life science private equity team at Rothschild Asset Management, was responsible for the launch of the first dedicated biotechnology fund for the Australian market and the conception and launch of the International Biotechnology Trust. He is currently the Managing Director of Bioscience Managers Pty Ltd, responsible for the BM Asia Pacific Heathcare Fund. During the past three years Mr Curnock Cook has also served as a director of the following other listed companies: Bioxyne Ltd (Appointed 7 May 2012 – resigned July 2014) Phylogica Ltd* (Appointed March 2012) AmpliPhi Bioscience Corporation Inc* (Appointed July 1995) Sea Dragon Marine Oils Ltd* (Appointed 15 October 2012) Eacom Timber Corporation (Appointed 1997 – resigned June 2013) Rex Bionics plc* (Appointed 27 February 2012) Adherium Ltd* (Appointed July 2015)
